Acenocoumarol

Acenocoumarol

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	X
Routes of administration	Oral
ATC code	B01AA07 ( WHO )
Legal status
Legal status	UK: POM (Prescription only)
Pharmacokinetic data
Metabolism	Hepatic
Elimination half-life	8 to 11 hours
Identifiers
IUPAC name (RS)-4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one
CAS Number	152-72-7  Y
PubChem CID	9052
DrugBank	DB01418  Y
ChemSpider	10443441  Y
UNII	I6WP63U32H
KEGG	D07064  Y
ChEBI	CHEBI:53766  Y
ChEMBL	ChEMBL397420  Y
CompTox Dashboard (EPA)	DTXSID2022541
ECHA InfoCard	100.005.281
Chemical and physical data
Formula	C19H15NO6
Molar mass	353.330 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
Melting point	196 to 199 °C (385 to 390 °F)
SMILES CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
InChI InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3 Y Key:VABCILAOYCMVPS-UHFFFAOYSA-N Y
(verify)

Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist (like warfarin). It is a derivative of coumarin and is generic, so is marketed under many brand names worldwide. ^[1]

References

1. "International listings for acenocoumarol". Drugs.com.

Further reading

• Cesar JM, García-Avello A, Navarro JL, Herraez MV (October 2004). "Aging and oral anticoagulant therapy using acenocoumarol". Blood Coagulation & Fibrinolysis. 15 (8): 673–676. doi:10.1097/00001721-200412000-00007. PMID   15613922. S2CID   19214006.
• Lengyel M (December 2004). "[Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation?]". Orvosi Hetilap. 145 (52): 2619–2621. PMID   15724697.
• Ufer M (2005). "Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol". Clinical Pharmacokinetics. 44 (12): 1227–1246. doi:10.2165/00003088-200544120-00003. PMID   16372822. S2CID   42970169.
• Montes R, Ruiz de Gaona E, Martínez-González MA, Alberca I, Hermida J (April 2006). "The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients". British Journal of Haematology. 133 (2): 183–187. doi:10.1111/j.1365-2141.2006.06007.x. hdl: 10171/21989 . PMID   16611310. S2CID   369821.

External links

• Diseases Database (DDB): 29202